Cyber knife surgery is a new cancer treatment procedure and is therefore uncommon and a tad expensive. It is the only radiosurgery system to bring together a linear accelerator, a robotic arm and the image guidance system. With its unique capabilities, Cyberknife can target lesions and tumors that might be considered unreachable by other radiosurgery systems. It is also the only system that can continually monitor and adjust in real-time for patient movement during treatment. Also, due to its precision, Cyberknife treatment for cancer targets the damaged region only without harming or affected the surrounding tissues or regions
Astrocytoma, Glioma, Glioblastoma Multiforme, Oligodendroglioma : –
CyberKnife offers superior conformance to tumour shape, which is important especially for recurrence after surgery and conventional radiotherapy. CyberKnife can also irradiate the tumour bed to delay or prevent recurrence.
Brain metastases : –
Radiosurgery may be equal to surgery for single metastases and better for multiple metastases. Advanced imaging allows CyberKnife® to treat those that are widely dispersed.
Spinal Tumours : –
CyberKnife® is regularly used to treat spinal metastases. It may also serve as a treatment for many primary spinal tumours.
Pituitary Adenoma : –
CyberKnife’s® staged treatments may help to avoid or minimize the risk of visual loss and other side effects associated with single-session radiosurgery. Its superior conformance minimizes irradiation of normal tissue, including the optic chiasm and hypothalamus.
Hemangioblastoma : –
CyberKnife® non-invasively treats the tumour nodule, usually in one session, even in hard-to-reach areas. This is especially beneficial for Von Hippel Lindau disease patients who can become disabled by multiple surgeries.
Skull Base Tumours : –
The proximity of these tumours to vital nerve and vascular structures makes them surgically problematic.
Meningioma : –
For smaller meningiomas, radiosurgery is an ideally non-invasive therapy. CyberKnife® is especially safe for meningiomas adjacent to critical structures because it can be delivered in fractions.
Neurofibroma & Schwannoma : –
While these tumours’ resistance to radiation makes conventional radiotherapy an option only when surgery is not, CyberKnife’s® conformance makes it an effective alternative to radiation therapy and surgery for selected patients.
Acoustic Neuroma : –
Studies show that CyberKnife® treatment in stages offers the highest rates ever achieved for hearing and facial-nerve preservation besides effective control of the tumour-growth.
Intracranial AVMs : –
With CyberKnife®, we can treat locations that can’t be safely approached with microsurgery or endovascular therapy. Selected AVMs have an 80% chance of disappearing after a single treatment session though it may take some time. CyberKnife® can also be used in conjunction with other therapies to remove remnants.
Spinal AVMs : –
CyberKnife® is the first and the only system to offer radiosurgical treatment of spinal AVMs .It provides the same or even more accuracy and success as for intracranial AVMs